EFG Asset Management (North America) Corp. - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 249 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.5%.

Quarter-by-quarter ownership
EFG Asset Management (North America) Corp. ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$1,584,364
+21.2%
24,031
-5.3%
0.35%
+19.0%
Q4 2022$1,307,423
-29.9%
25,377
-7.2%
0.29%
-31.8%
Q3 2022$1,865,000
-5.5%
27,332
-37.4%
0.43%
+3.6%
Q2 2022$1,974,000
-31.3%
43,652
-22.8%
0.42%
-3.3%
Q1 2022$2,872,000
+6.3%
56,550
-0.9%
0.43%
+22.2%
Q4 2021$2,701,00057,0550.35%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders